+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Test Type; End User, and Geography

  • ID: 5023741
  • Report
  • April 2020
  • Region: Global
  • 156 Pages
  • The Insight Partners
UP TO OFF until Jun 30th 2022

FEATURED COMPANIES

  • BD
  • Danaher
  • GE
  • Hologic, Inc.
  • Koninklijke Philips N.V..
  • Myriad Genetics, Inc.
The breast cancer screening was valued at US$ 4,638.63 million in 2019 and is projected to reach US$ 6,209.25 million by 2027; it is expected to grow at a CAGR of 4.8% from 2020 to 2027.

The growing prevalence of breast cancer and increasing investments in breast cancer management are the major factors driving the breast cancer screening market. However, the high cost of breast cancer screening is a chief factor limiting the market growth. Breast cancer is among the prime causes of deaths in the world, and it is profoundly affecting the quality of life. Thus, it acts as a burden on society if not diagnosed and treated on time. As per the estimations by the American Cancer Society, it is the most common type of cancer in the US as it caused morbidity in ~234,087 people, leading to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, which further led to ~19,376 deaths in that years. Further, as per the Globocan report, in 2018, there were ~367,900 new cases of breast cancer and 97,972 deaths due to the same in China. In India, NGOs, government agencies, and charity organizations are emphasizing on breast cancer awareness among population to promote early detection, provide comprehensive treatment module, and extend support for breast cancer management. As per the Globocan report estimation, in 2018, India reported ~162,468 new breast cancer cases, with 87,090 deaths due to the same.

The global breast cancer screening market has been segmented on the basis of test type and end user. The breast cancer screening market, by test type, has been segmented into blood marker tests, imaging test, genetic test, and immunohistochemistry test. The imaging test segment held the largest share of the market in 2019, and it is also anticipated to register the highest CAGR in the market during the forecast period. Based on end user, the breast cancer screening has been segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019 and is expected to register fastest CAGR during the forecast period.

A few of the essential primary and secondary sources referred to during the preparation of the report are Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, and National Cancer Foundation.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the breast cancer screening market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • BD
  • Danaher
  • GE
  • Hologic, Inc.
  • Koninklijke Philips N.V..
  • Myriad Genetics, Inc.

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Breast Cancer Screening Market - By Test Type
1.3.2 Global Breast Cancer Screening Market - By End User
1.3.3 Global Breast Cancer Screening Market - By Geography
2. Breast Cancer Screening Market - Key Takeaways
2.1 Global Breast Cancer Screening Market Overview
2.2 Global Breast Cancer Screening Market, By Geography (US$ Million)
2.3 Global Breast Cancer Screening Market- Leading Country Markets (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Breast Cancer Screening - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinion
5. Breast Cancer Screening- Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Globally Growing Breast Cancer Prevalence
5.1.2 Increasing Investments in Breast Cancer Management
5.2 Key Market Restraints
5.2.1 High Cost of Breast Cancer Screening
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Consistent Launch of New Screening Products
5.5 Impact Analysis
6. Breast Cancer Screening Market - Global Analysis
6.1 Global Breast Cancer Screening Market Revenue Forecast and Analysis
6.2 Global Breast cancer screening Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Breast Cancer Screening Market Analysis - By Test Type
7.1 Overview
7.2 Breast Cancer Screening Market Revenue Share, by Test Type (2019 and 2027)
7.3 Blood Marker Test
7.3.1 Overview
7.3.2 Blood Marker Tests:Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Imaging Test
7.5.1 Overview
7.5.2 Imaging Test: Breast Cancer Screening Market- Revenue and Forecast to 2027 (US$ Million)
7.6 Genetic Test
7.6.1 Overview
7.6.2 Genetic Test: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
7.7 Immunohistochemistry Test
7.7.1 Overview
7.7.2 Immunohistochemistry Test: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
8. Breast Cancer Screening Market - By End User
8.1 Overview
8.2 Breast Cancer Screening Market, by End-User, 2019 and 2027 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Diagnostics Centers
8.4.1 Overview
8.4.2 Diagnostic Centers: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Research Laboratories
8.5.1 Overview
8.6 Research Laboratories: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Cancer Institutes
8.7.1 Overview
8.8 Cancer Institutes: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
9. Breast Cancer Screening Market - Geographic Analysis
9.1 North America: Breast Cancer Screening Market
9.1.1 Overview
9.1.2 North America: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.3 North America: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.1.4 North America: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.1.5 North America: Breast Cancer Screening Market, by Country, 2019 & 2027 (%)
9.1.6 US: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.1 US: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.6.2 US: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.1.6.3 US: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.1.7 Canada: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Canada: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Canada: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.1.7.3 Canada: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.1.8 Mexico: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Mexico: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Mexico: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.1.8.3 Mexico: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.2 Europe: Breast Cancer Screening Market
9.2.1 Overview
9.2.2 Europe: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.3 Europe: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.2.4 Europe: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.2.5 Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.2.6 Germany: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.1 Germany: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.6.2 Germany: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.2.6.3 Germany: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.2.7 UK: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.1 UK: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.7.2 UK: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.2.7.3 UK: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.2.8 France: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.1 France: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.8.2 France: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.2.8.3 France: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.2.9 Spain: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.1 Spain: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.9.2 Spain: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.2.9.3 Spain: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.2.10 Italy: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.1 Italy: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.2.10.2 Italy: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.2.10.3 Italy: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.3 Asia Pacific: Breast Cancer Screening Market
9.3.1 Overview
9.3.2 Asia Pacific: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.3 Asia Pacific: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.3.4 Asia Pacific: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.3.5 Asia Pacific: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.3.6 China: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.1 China: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.6.2 China: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.3.6.3 China: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.3.7 Japan: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.1 Japan: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.7.2 Japan: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.3.7.3 Japan: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.3.8 India: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.1 India: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.8.2 India: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.3.8.3 India: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.3.9 South Korea: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.1 South Korea: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.9.2 South Korea: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.3.9.3 South Korea: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.3.10 Australia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.1 Australia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.3.10.2 Australia: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.3.10.3 Australia: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.4 Middle East & Africa: Breast Cancer Screening Market
9.4.1 Overview
9.4.2 Middle East & Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.4.3 Middle East & Africa: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.4.4 Middle East & Africa: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.4.5 Middle East & Africa: Breast Cancer Screening Market Share by Country - 2019 & 2027, (%)
9.4.6 Saudi Arabia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.1 Saudi Arabia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.4.6.2 Saudi Arabia: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.4.6.3 Saudi Arabia: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.4.7 UAE: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.1 UAE: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.4.7.2 UAE: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.4.7.3 UAE: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.4.8 South Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
9.4.8.1 South Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.4.8.2 South Africa: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.4.8.3 South Africa: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.5 South and Central America: Breast Cancer Screening Market
9.5.1 Overview
9.5.2 South and Central America: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
9.5.3 South and Central America: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.5.4 South and Central America: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.5.5 South and Central America: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
9.5.6 Brazil: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.1 Brazil: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.5.6.2 Brazil: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.5.6.3 Brazil: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
9.5.7 Argentina: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.1 Argentina: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
9.5.7.2 Argentina: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
9.5.7.3 Argentina: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
10. Impact Of COVID-19 Pandemic On Global Breast Cancer Screening Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment Of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
11. Breast Cancer Screening Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in The Breast Cancer Screening Market, 2016-2020
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Breast Cancer Screening Market - Key Company Profiles
12.1 General Electric Company
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Siemens Healthineers AG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Exact Sciences Corporation
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hologic, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 BD
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Myriad Genetics, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Oncocyte Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Danaher
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 POC Medical Systems
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Koninklijke Philips N.V..
  • Hologic, Inc.
  • BD
  • Myriad Genetics, Inc.
  • Siemens Healthcare GMBH
  • Exact Sciences Corporation
  • Oncocyte Corporation
  • POC Medical Systems
  • Danaher
  • GE
Note: Product cover images may vary from those shown